Tadalafil for the treatment of pulmonary arterial hypertension

Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension

(2013) Gérald Simonneau   ANNALS OF INTERNAL MEDICINE

Tadalafil in Geriatric Patients With Pulmonary Arterial Hypertension

(2011) Carl Arneson et al.   CHEST

Relationship Between Dosing and Common Adverse Events With Tadalafil in Patients With Pulmonary Arterial Hypertension

(2011) Erika Berman Rosenzweig et al.   CHEST

Pulmonary arterial hypertension: a comparison between children and adults

(2011) R. J. Barst et al.   EUROPEAN RESPIRATORY JOURNAL

Predicting Survival in Pulmonary Arterial Hypertension

(2010) Raymond L. Benza et al.   CIRCULATION

Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

(2010) Marc Humbert et al.   CIRCULATION

Cyclic Nucleotide Phosphodiesterases (PDE) and Peptide Motifs

(2010) Therese Keravis et al.   CURRENT PHARMACEUTICAL DESIGN

Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension

(2010) Vallerie V. McLaughlin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

(2009) et al.   CIRCULATION

Tadalafil Therapy for Pulmonary Arterial Hypertension

(2009) Nazzareno Galiè et al.   CIRCULATION

Vision Disorders and Phosphodiesterase Type 5 Inhibitors

(2009) Alan M. Laties   DRUG SAFETY

A meta-analysis of randomized controlled trials in pulmonary arterial hypertension

(2009) N. Galie et al.   EUROPEAN HEART JOURNAL

No clinically relevant pharmacokinetic and safety interactions of ambrisentan in combination with tadalafil in healthy volunteers

(2009) Rebecca Spence et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial Hypertension

(2009) Robyn J. Barst et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Diagnosis and Assessment of Pulmonary Arterial Hypertension

(2009) David B. Badesch et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Updated Clinical Classification of Pulmonary Hypertension

(2009) Gérald Simonneau et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Ambrisentan for the Treatment of Pulmonary Arterial Hypertension

(2008) Nazzareno Galiè et al.   CIRCULATION

Pharmacokinetic Interaction Between Tadalafil and Bosentan in Healthy Male Subjects

(2008) Rebecca E. Wrishko et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Pulmonary embolism after tadalafil ingestion

(2008) Huang-Chi Chen et al.   PHARMACY WORLD & SCIENCE